$CBOE

CBOE Explores Perpetual VIX Futures Without Monthly Expiry

CBOE is considering perpetual VIX futures with no fixed expiration dates, similar to contracts in cryptocurrency markets. According to Coin Bureau, this could offer continuous volatility exposure and reduce rollover needs, but may present hedging challenges. No launch date or final decision has been announced.

Original reporting
Published Oct 3, 2026, 4:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 3, 2026, 1:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CBOE Explores Perpetual VIX Futures Without Monthly Expiry — source image
Decision brief

The 30-second read

$CBOENeutralLow
01

Why it matters

The perpetual VIX futures idea mirrors crypto perpetual contracts, potentially broadening the VIX market's user base.

02

Market read

Introduces a novel product concept that could affect volatility trading strategies but lacks immediate price impact.

03

What to watch

Funding cost structures and hedging challenges could deter market‑maker participation.

Relevance 5/10Novelty 5/10Timing: immediate

Background

CBOE is a leading U.S. options and futures exchange that periodically evaluates new contract types.

Company-level read

Ticker impact

$CBOENeutralMedium confidence
Context

CBOE announced it is exploring perpetual VIX futures, a new product concept not previously disclosed.

Expected impact

likely limited pressure as market prices in the speculative product idea.

Evidence & confidence

The announcement is novel but the product is not yet launched; impact depends on final specifications.

Market effects

May influence volatility derivatives and crypto‑inspired product design across exchanges.

Primarily U.S. derivatives market, with possible spillover to global volatility trading.

Limited to market participants interested in VIX exposure; not a broad market mover.

Counterpoint

Without clear regulatory approval, the concept may never materialize, limiting any real impact.

Key entities

  • CBOE Global Markets

    U.S.-listed exchange exploring new derivative structures.

Related articles

$CBOEHigh

Goldman Sachs upgrades CBOE Holdings stock rating to neutral

Goldman Sachs upgraded CBOE Holdings (CBOE) to Neutral with a $300 price target, citing attractive valuation and reduced competitive risks. The stock has risen 44.6% since being added to the Americas Sell List. CBOE reported Q2 2026 earnings of $3.56 per share, beating estimates, with net revenue of $732 million, up 25% YoY. Piper Sandler maintains an Overweight rating with a $320 target.